Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1997-01-07
1998-12-29
Jones, W. Gary
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 912, 536 2433, 935 8, 935 77, 935 78, C12Q 168, C12P 1934, C07H 2104
Patent
active
058539956
ABSTRACT:
The present invention provides a method of screening individuals at risk for developing diseases caused by trinucleotide repeat sequence instability. Specifically, the present invention is drawn to screening individuals at risk for developing autosomal dominant spinocerebellar ataxia type 6 by determining the length of a CAG trinucleotide repeat in the .alpha..sub.1A calcium channel gene of the individual. In addition, there is provided a method of identifying genes which are disease-causing due to trinucleotide repeat sequence instability by large scale genotyping.
REFERENCES:
Margolis et al. Hum. Mol. Genet. 5:607-616, May 1996.
Riggins et al Nature Genetics 2:186-191, Nov. 1992.
Chung et al Nature Genetics 5:254-258, Nov. 1993.
Sanpei et al Nature Genetics 14:277-284, Nov. 1996.
Adler Benjamin Aaron
Jones W. Gary
Research Development Foundation
Shoemaker Debra
LandOfFree
Large scale genotyping of diseases and a diagnostic test for spi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Large scale genotyping of diseases and a diagnostic test for spi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Large scale genotyping of diseases and a diagnostic test for spi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1423356